Targeting the ATR-CHK1 Axis in Cancer Therapy

by Stuart Rundle, Alice Bradbury, Yvette Drew, Nicola J. Curtin
Published 2017-04-01

Characterisation of Ovarian Cancer Cell Line NIH-OVCAR3 and Implications of Genomic, Transcriptomic, Proteomic and Functional DNA Damage Response Biomarkers for Therapeutic Targeti...

by Alice Bradbury, Rachel O’Donnell, Yvette Drew, Nicola J. Curtin, Sweta Sharma Saha
Published 2020-07-01

Genomic, Transcriptomic, and Functional Alterations in DNA Damage Response Pathways as Putative Biomarkers of Chemotherapy Response in Ovarian Cancer

by Sweta Sharma Saha, Lucy Gentles, Alice Bradbury, Dominik Brecht, Rebecca Robinson, Rachel O’Donnell, Nicola J. Curtin, Yvette Drew
Published 2021-03-01

Exploring the Frequency of Homologous Recombination DNA Repair Dysfunction in Multiple Cancer Types

by Lucy Gentles, Bojidar Goranov, Elizabeth Matheson, Ashleigh Herriott, Angelika Kaufmann, Sally Hall, Asima Mukhopadhyay, Yvette Drew, Nicola J. Curtin, Rachel L O’Donnell
Published 2019-03-01

Characterization and drug sensitivity of a novel human ovarian clear cell carcinoma cell line genomically and phenotypically similar to the original tumor

by Miriam Franklin, Lucy Gentles, Elizabeth Matheson, Nick Bown, Paul Cross, Angela Ralte, Connor Gilkes‐Immeson, Alice Bradbury, Maryam Zanjirband, John Lunec, Yvette Drew, Rachel O'Donnell, Nicola J. Curtin
Published 2018-09-01